TY - JOUR
T1 - Effect of association of temozolomide with other chemotherapic agents on cell growth inhibition in glioma cell lines
AU - Balzarotti, Marco
AU - Ciusani, Emilio
AU - Calatozzolo, Chiara
AU - Croci, Danilo
AU - Boiardi, Amerigo
AU - Salmaggi, Andrea
PY - 2004
Y1 - 2004
N2 - Despite progresses in surgery and treatments of malignant gliomas, prognosis of these tumors remains poor, with a median life expectancy of 12 months in glioblastomas. Chemotherapy (mostly with nitrosoureas) has been demonstrated to prolong overall survival, but the entity of this improvement is slight and disease recurrence/progression is the rule, stressing the need for multimodality treatment. In this work we investigated the effect of association of temozolomide (TMZ), an orally bioavailable alkylating agent, with three chemotherapeutic drugs, liposomal doxombicin (DOXO), cis-platinum (CDDP), and topotecan (TP), on cell growth of A172, U373, U138, U87, and SW1783 (all human glioma cell lines). Results indicate a synergistic effect (C1 <1) of TMZ in association with liposomal DOXO and CDDP on cell growth inhibition in most of the studied cell lines (A172, U373, U138, U87). Synergistic effect also has been obtained after treatment of A172 and U373 with TMZ and TP in association. In conclusion, our results confirm the potential effect of association of chemotherapic drugs with different mechanisms of action in the treatment of gliomas.
AB - Despite progresses in surgery and treatments of malignant gliomas, prognosis of these tumors remains poor, with a median life expectancy of 12 months in glioblastomas. Chemotherapy (mostly with nitrosoureas) has been demonstrated to prolong overall survival, but the entity of this improvement is slight and disease recurrence/progression is the rule, stressing the need for multimodality treatment. In this work we investigated the effect of association of temozolomide (TMZ), an orally bioavailable alkylating agent, with three chemotherapeutic drugs, liposomal doxombicin (DOXO), cis-platinum (CDDP), and topotecan (TP), on cell growth of A172, U373, U138, U87, and SW1783 (all human glioma cell lines). Results indicate a synergistic effect (C1 <1) of TMZ in association with liposomal DOXO and CDDP on cell growth inhibition in most of the studied cell lines (A172, U373, U138, U87). Synergistic effect also has been obtained after treatment of A172 and U373 with TMZ and TP in association. In conclusion, our results confirm the potential effect of association of chemotherapic drugs with different mechanisms of action in the treatment of gliomas.
KW - Cis-platinum
KW - Doxorubicin
KW - Glioma
KW - Locoregional
KW - Temozolomide
KW - Topotecan
UR - http://www.scopus.com/inward/record.url?scp=4043169888&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=4043169888&partnerID=8YFLogxK
M3 - Article
C2 - 15301423
AN - SCOPUS:4043169888
VL - 14
SP - 325
EP - 330
JO - Oncology Research
JF - Oncology Research
SN - 0965-0407
IS - 7-8
ER -